Dare Bioscience, Inc. — Investor Relations & Filings
Filings indexed
729
across all filing types
Latest filing
2026-05-18
Regulatory Filings
Country
US
United States of America
Listing
US
DARE
Dare Bioscience, Inc. is a clinical-stage biopharmaceutical company focused on advancing innovative products for women's health. The company conducts end-to-end clinical development of therapies designed to address unmet needs in areas such as contraception, sexual health, vaginal health, and menopause. Its pipeline includes candidates like Ovaprene®, a hormone-free monthly contraceptive, and a topical sildenafil cream for female sexual arousal disorder. Dare Bioscience emphasizes a rigorous, science-based approach to develop medically credible and evidence-based solutions, aiming to close critical gaps in female healthcare.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 8-K | 2026-05-18 | English | |
| 10-Q | 2026-05-14 | English | |
| 8-K | 2026-05-14 | English | |
| ARS - Dare Bioscience, Inc. (0001401914) (Filer) | 2026-04-28 | English | |
| DEF 14A - Dare Bioscience, Inc. (0001401914) (Filer) | 2026-04-28 | English | |
| 8-K - Dare Bioscience, Inc. (0001401914) (Filer) | 2026-04-22 | English |
Browse filings by year
19 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 46460962 | 8-K | 2026-05-18 | English | ||
| 46228586 | 10-Q | 2026-05-14 | English | ||
| 46297374 | 8-K | 2026-05-14 | English | ||
| 38171736 | ARS - Dare Bioscience, Inc. (0001401914) (Filer) | 2026-04-28 | English | ||
| 38155812 | DEF 14A - Dare Bioscience, Inc. (0001401914) (Filer) | 2026-04-28 | English | ||
| 35255512 | 8-K - Dare Bioscience, Inc. (0001401914) (Filer) | 2026-04-22 | English | ||
| 34662069 | 8-K - Dare Bioscience, Inc. (0001401914) (Filer) | 2026-04-17 | English | ||
| 34440986 | 8-K - Dare Bioscience, Inc. (0001401914) (Filer) | 2026-04-13 | English | ||
| 33052005 | 10-K - Dare Bioscience, Inc. (0001401914) (Filer) | 2026-03-26 | English | ||
| 33051992 | 8-K - Dare Bioscience, Inc. (0001401914) (Filer) | 2026-03-26 | English | ||
| 32967570 | 8-K - Dare Bioscience, Inc. (0001401914) (Filer) | 2026-03-17 | English | ||
| 32891310 | 8-K - DARE BIOSCIENCE, INC. (0001401914) (Filer) | 2026-03-02 | English | ||
| 32891305 | 4 - DARE BIOSCIENCE, INC. (0001401914) (Filer) | 2026-02-20 | English | ||
| 29417093 | 4 Filing | 2026-02-02 | English | ||
| 29417091 | 4 Filing | 2026-02-02 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
GemVax & KAEL Co.,Ltd.
Clinical-stage biopharma developing therapeutics for neurod…
|
082270 | KR | Manufacturing |
|
Gencurix Inc.
Develops and commercializes diagnostic solutions for precis…
|
229000 | KR | Manufacturing |
|
GENEDRIVE PLC
Develops rapid, point-of-care pharmacogenetic testing platf…
|
GDR | GB | Manufacturing |
|
GENELUX Corp
Clinical-stage biopharma developing oncolytic viral immunot…
|
GNLX | US | Manufacturing |
|
GENEMATRIX INC.
Develops multiplex PCR diagnostic products for infectious d…
|
109820 | KR | Manufacturing |
|
Generation Bio Co.
Develops siRNA therapeutics delivered via ctLNPs for T cell…
|
GBIO | US | Manufacturing |
|
GENETIC SIGNATURES LIMITED
Molecular diagnostics company using proprietary 3base techn…
|
GSS | AU | Manufacturing |
|
Genexine, Inc.
Clinical-stage biotech developing long-acting therapeutics …
|
095700 | KR | Manufacturing |
|
Genfit S.A.
Biopharmaceutical firm developing therapies and diagnostics…
|
GNFT | US | Manufacturing |
|
GenFleet Therapeutics (Shanghai) Inc.
Clinical-stage biopharma specializing in first-in-class onc…
|
2595 | HK | Manufacturing |
Dare Bioscience, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/34825/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=34825 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=34825 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=34825 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 34825}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Dare Bioscience, Inc. (id: 34825)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.